Cargando…

Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma

Detalles Bibliográficos
Autores principales: Bajaj, Gaurav, Gupta, Manish, Feng, Yan, Statkevich, Paul, Roy, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697692/
https://www.ncbi.nlm.nih.gov/pubmed/28800166
http://dx.doi.org/10.1002/jcph.962
_version_ 1783280667711242240
author Bajaj, Gaurav
Gupta, Manish
Feng, Yan
Statkevich, Paul
Roy, Amit
author_facet Bajaj, Gaurav
Gupta, Manish
Feng, Yan
Statkevich, Paul
Roy, Amit
author_sort Bajaj, Gaurav
collection PubMed
description
format Online
Article
Text
id pubmed-5697692
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56976922017-11-28 Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma Bajaj, Gaurav Gupta, Manish Feng, Yan Statkevich, Paul Roy, Amit J Clin Pharmacol Therapeutics John Wiley and Sons Inc. 2017-08-11 2017-12 /pmc/articles/PMC5697692/ /pubmed/28800166 http://dx.doi.org/10.1002/jcph.962 Text en © 2017, The Authors. The Journal of Clinical Pharmacology Published by Wiley Periodicals, Inc. on behalf of American College of Clinical Pharmacology This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Therapeutics
Bajaj, Gaurav
Gupta, Manish
Feng, Yan
Statkevich, Paul
Roy, Amit
Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma
title Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma
title_full Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma
title_fullStr Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma
title_full_unstemmed Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma
title_short Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma
title_sort exposure–response analysis of nivolumab in patients with previously treated or untreated advanced melanoma
topic Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697692/
https://www.ncbi.nlm.nih.gov/pubmed/28800166
http://dx.doi.org/10.1002/jcph.962
work_keys_str_mv AT bajajgaurav exposureresponseanalysisofnivolumabinpatientswithpreviouslytreatedoruntreatedadvancedmelanoma
AT guptamanish exposureresponseanalysisofnivolumabinpatientswithpreviouslytreatedoruntreatedadvancedmelanoma
AT fengyan exposureresponseanalysisofnivolumabinpatientswithpreviouslytreatedoruntreatedadvancedmelanoma
AT statkevichpaul exposureresponseanalysisofnivolumabinpatientswithpreviouslytreatedoruntreatedadvancedmelanoma
AT royamit exposureresponseanalysisofnivolumabinpatientswithpreviouslytreatedoruntreatedadvancedmelanoma